Am J Transplant, Volume 20, Suppl 3 Archives - Page 157 of 223 - ATC Abstracts

2020 American Transplant Congress
Living Donor Gender Disparities Vary by Donor-Recipient Familial Relationship
Y. Chen¹, Y. Hung², C. de Crescenzo¹, C. Rickert¹, Y. Hsu³, H. Yeh¹, D. Chang¹
¹Department of Surgery, Massachusetts General Hospital, Boston, MA, ²Department of Surgery, Sinai Hospital of Baltimore, Baltimore, MA, ³Department of Social and Behavioral Sciences, Harvard School of Public Health, Boston, MA
*Purpose: Women are more likely to be living transplant donors and less likely to be recipients. It has been difficult to distinguish how much of…
2020 American Transplant Congress
Transplant Regimen Adherence for Kidney Recipients by Engaging Information Technologies: Update on the Take It Trial
E. Yoon¹, S. Hurr¹, L. Curtis¹, D. Ladner², S. Nair³, M. S. Wolf¹
¹Center for Applied Health Research on Aging (CAHRA), Northwestern University Feinberg School of Medicine, Chicago, IL, ²Surgery, Northwestern Medicine, Chicago, IL, ³Nephrology and Hypertension, Mayo Clinic, Scottsdale, AZ
*Purpose: In 2017, the TAKE IT trial began its evaluation of a multifaceted, technology-enabled, transplant center-based intervention to monitor medication adherence behaviors among Kidney Transplant…
2020 American Transplant Congress
Kidney after Intestinal Transplantation: A Comparison with Combined Kidney with Intestinal Transplant. A UNOS Database Analysis
A. Sharfuddin, M. Panezai, O. Adebiyi, T. Taber, M. Yaqub
Indiana University School of Medicine, Indianapolis, IN
*Purpose: There is limited data on outcomes for patients receiving a isolated kidney transplant (KAIT) after any prior Multi-organ or Isolated Intestinal transplant (IT). We…
2020 American Transplant Congress
Immunomodulation with FasL Presenting Biomaterials Achieves Long-Term Survival of Allogeneic Islets in the Absence of Chronic Immunosuppression in a Non-Human Primate Model
J. Lei¹, H. Deng¹, T. Chen¹, K. Lee¹, C. Peters¹, Z. Yang¹, K. Deng¹, G. Rickert¹, I. Rosales¹, N. Serifis¹, M. Coronel², M. Hunckler², E. Yolcu³, H. Shirwan³, A. García², J. Markmann¹
¹Surgery, Mass General, Boston, MA, ²School of Mechanical Engineering, Georgia Institute of Technology, Atlanta, GA, ³School of Mechanical Engineering, University of Louisville School of Medicine, Louisville, KY
*Purpose: The full potential of islet transplantation will only be realized by the development of tolerogenic strategies that obviate the need for maintenance immunosuppressants. We…
2020 American Transplant Congress
Outcomes Associated with Mycophenolate Weight-Based Dosing in Varying Immunologic Risk Kidney Transplant Recipients
A. A. Al-Bahou, A. R. Webb, M. Bloxam, L. J. Bowman Anger, R. S. Baliga, A. J. Brueckner
Tampa General Hospital, Tampa, FL
*Purpose: Mycophenolate acid (MPA) is traditionally dosed in kidney transplant recipients (KTR) using the FDA-approved fixed dosing which is irrespective of patient-specific variables such as…
2020 American Transplant Congress
CHAIR Score: A Novel Risk Stratification in Transplant Renal Artery Stenosis
X. Tian, W. Duan, T. Yan, X. Wu
Henan Province People's Hospital, Zhengzhou, Henan Province, China
*Purpose: The aim of the study is to evaluate the clinical application of CHAIR score based on creatinine (C), hypertension (H), age (A), imaging evidence…
2020 American Transplant Congress
The Impact of Cold Ischaemia Time on Living Donor Kidney Transplantation Outcomes
S. C. van de Laar¹, M. Robb², R. Hogg², V. Papalois¹, F. J. Dor¹
¹Department of Surgery & Cancer, Imperial College London, Imperial College Renal and Transplant Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust, White City, London, United Kingdom, ²NHS Blood and Transplant, Bristol, United Kingdom
*Purpose: Living donor KTx (LDKT) provides the best option for patients with end-stage kidney disease (ESKD). ESKD patients who have an incompatible living donor still…
2020 American Transplant Congress
Sequential Protocol Biopsies Post-Liver Transplant from Donors with Moderate Macrosteatosis: What Happens to the Fat?
K. Croome, D. Livingston, C. Taner, R. Nakhleh
Mayo Clinic Jacksonville, Jacksonville, FL
*Purpose: The number of steatotic deceased donor livers encountered has continued to rise as a result of the obesity epidemic. Little is known about the…
2020 American Transplant Congress
Anticipated Cost Savings of Using Lungs from Hepatitis C-Positive Lung Donors for Hepatitis C-Negative Recipients
K. Ryland¹, J. Mallea², J. Moriarty³, L. White⁴, B. Borah⁵, J. Naessens³
¹Transplantation, Mayo Clinic, Jacksonville, FL, ²Medicine, Mayo Clinic, Jacksonville, FL, ³Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, ⁴Health Sciences Research, Mayo Clinic, Jacksonville, FL, ⁵Health Sciences Research, Mayo Clinic, Rochester, MN
*Purpose: We assessed the cost savings generated by additional organ availability due to utilizing lungs from hepatitis-C infected donors for transplantation in comparison to existing…
2020 American Transplant Congress
TIM-4+ Kupffer Cells Play Homeostatic Roles in Liver Ischemia Reperfusion Injury
M. Ni¹, J. Zhang¹, R. Sosa², S. Kageyama¹, R. Busuttil¹, R. Elaine², J. Kupiec-Weglinski¹, X. Wang³, Y. Zhai¹
¹Dumont-UCLA Transplant Center, Los Angeles, CA, ²Pathology, David Geffen School of Medicine-UCLA, Los Angeles, CA, ³Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China
*Purpose: Liver ischemia reperfusion injury (IRI) remains a significant clinical problem. Although the molecular mechanism of liver inflammatory response against IR has been studied extensively,…